Form 4/A for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-04-13 00:00:00 ET · period of report 2022-04-01 · accession 0001562180-22-003383 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2022-04-13 | 2022-04-01+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $7.20 | +73.7K | 88.4K | +501% | +$530.4K |
| DMA | 2022-04-13 | 2022-04-01+ | SNDX | Morrison Briggs | Pres, Head of R, D, Dir | M - OptEx | $0.00 | -73.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-04 | M | A | 3,128 | $7.20 | 20,964 | D | — | — | (F1) The Reporting Person is not reporting any new transactions in this filing. Amendment filed to correct previously filed Form that contained an incorrect option exercise price and expiration date. |
| 2 | Common | Common Stock | 2022-04-01 | M | A | 70,545 | $7.20 | 88,381 | D | — | — | (F1) The Reporting Person is not reporting any new transactions in this filing. Amendment filed to correct previously filed Form that contained an incorrect option exercise price and expiration date. |
| 3 | Derivative | Stock Options (Right to buy) | 2022-04-04 | M | D | 3,128 | $0.00 | 0 | D | $7.20 · — to 2025-06-30 | 3,128 Common Stock | (F1) The Reporting Person is not reporting any new transactions in this filing. Amendment filed to correct previously filed Form that contained an incorrect option exercise price and expiration date. (F2) This option is fully vested. |
| 4 | Derivative | Stock Options (Right to buy) | 2022-04-01 | M | D | 70,545 | $0.00 | 0 | D | $7.20 · — to 2025-06-30 | 70,545 Common Stock | (F1) The Reporting Person is not reporting any new transactions in this filing. Amendment filed to correct previously filed Form that contained an incorrect option exercise price and expiration date. (F2) This option is fully vested. |